Skip to main content Accessibility help
×
Home
  • Cited by 2
  • Print publication year: 2015
  • Online publication date: August 2015

15 - Vascular dementia and vascular cognitive impairment

Related content

Powered by UNSILO
1.Román, GC, Tatemichi, TK, Erkinjuntti, T, Cummings, JL, Masdeu, JC, Garcia, JH, Amaducci, L, Orgogozo, JM, Brun, A, Hofman, A, et al. Vascular dementia: diagnostic criteria for research studies. Report of the NINDS-AIREN International Workshop. Neurology 1993;43:250–60.
2.Bowler, JV, Hachinski, V. The concept of vascular cognitive impairment. In: Erkinjuntti, T, Gauthier, S, eds. Vascular Cognitive Impairment. London: Dunitz; 2002:925.
3.Bowler, JV, Hachinski, V. Vascular cognitive impairment – a new concept. In: Bowler, JV, Hachinski, V, eds. Vascular Cognitive Impairment. Preventable Dementia. Oxford: Oxford University Press; 2002:321–37.
4.Hachinski, V, Ladecola, C, Petersen, RC, Breteler, MM, Nyenhuis, DL, Black, SE, Powers, WJ, DeCarli, C, Merino, JG, Kalaria, RN, Vinters, HV, Holtzman, DM, Rosenberg, GA, Wallin, A, Dichgans, M, Marler, JR, Leblanc, GG. National Institute of Neurological Disorders and Stroke-Canadian Stroke Network vascular cognitive impairment harmonization standards. Stroke 2006;37:2220–41.
5.Sachdev, P. Is it time to retire the term “dementia”? J Neuropsychiatry Clin Neurosci 2000;12:276–9.
6.Sachdev, P, Kalaria, R, O’Brien, J, Skoog, I, Alladi, S, Black, SE, Blacker, D, Blazer, DG, Chen, C, Chui, H, Ganguli, M, Jellinger, K, Jeste, DV, Pasquier, F, Paulsen, J, Prins, N, Rockwood, K, Roman, G, Scheltens, P. Alzheimer Diagnostic Criteria for Vascular Cognitive Disorders: a VASCOG statement. Alzheimer Dis Assoc Disord 2014;28(3):206–18.
7.Douiri, A, McKevitt, C, Emmett, ES, Rudd, AG, Wolfe, CD. Long-term effects of secondary prevention on cognitive function in stroke patients. Circulation 2013;128:1341–8.
8.Dichgans, M, Zietemann, V. Prevention of vascular cognitive impairment. Stroke 2012;43:3137–46.
9.Kavirajan, H, Schneider, LS. Efficacy and adverse effects of cholinesterase inhibitors and memantine in vascular dementia: a meta-analysis of randomised controlled trials. Lancet Neurol 2007;6:782–92.
10.Birks, J, McGuinness, B, Craig, D. Rivastigmine for vascular cognitive impairment. Cochrane Database Syst Rev 2013;5:CD004744.
11.Shih, AY, Blinder, P, Tsai, PS, Friedman, B, Stanley, G, Lyden, PD, Kleinfeld, D. The smallest stroke: occlusion of one penetrating vessel leads to infarction and a cognitive deficit. Nat Neurosci 2013;16:5563.
12.López-Valdés, HE, Clarkson, AN, Ao, Y, Charles, AC, Carmichael, ST, Sofroniew, MV, Brennan, KC. Memantine enhances recovery from stroke. Stroke 2014;45:2093–100.
13.Sorbi, S, Hort, J, Erkinjuntti, T, Fladby, T, Gainotti, G, Gurvit, H, Nacmias, B, Pasquier, F, Popescu, BO, Rektorova, I, Religa, D, Rusina, R, Rossor, M, Schmidt, R, Stefanova, E, Warren, JD, Scheltens, P; EFNS Scientist Panel on Dementia and Cognitive Neurology. EFNS-ENS Guidelines on the diagnosis and management of disorders associated with dementia. Eur J Neurol 2012;19:1159–79.
14.Gould, N. Guidelines across the health and social care divides: the example of the NICE-SCIE dementia guideline. Int Rev Psychiatry 2011;23:365–70.
15.Fick, DM, Agostini, JV, Inouye, SK. Delirium superimposed on dementia: a systematic review. J Am Geriatr Soc 2002;50:1723–32.
16.Dasgupta, M, Hillier, LM. Factors associated with prolonged delirium: a systematic review. Int Psychogeriatr 2010;22:373–94.
17.van Eijk, MJ, Roes, KCB, Honing, MLH, et al. Effect of rivastigmine as an adjunct to usual care with haloperidol on duration of delirium and mortality in critically ill patients: a multicentre, double-blind, placebo-controlled randomised trial. Lancet 2010; 376:1829–37.
18.Erkinjuntti, T, Inzitari, D, Pantoni, L, Wallin, A, Scheltens, P, Rockwood, K, Roman, GC, Chui, H, Desmond, DW. Research criteria for subcortical vascular dementia in clinical trials. J Neural Transm Suppl 2000;59:2330.
19.Román, GC, Erkinjuntti, T, Wallin, A, et al. Subcortical ischaemic vascular dementia. Lancet Neurol 2002;1:426–36.
20.Dichgans, M, Markus, HS, Salloway, S, Verkkoniemi, A, Moline, M, Wang, Q, Posner, H, Chabriat, HS. Donepezil in patients with subcortical vascular cognitive impairment: a randomised double-blind trial in CADASIL. Lancet Neurol 2008;7:310–18.
21.Kalra, S, Grosset, DG, Benamer, HT. Differentiating vascular parkinsonism from idiopathic Parkinson’s disease: a systematic review. Mov Disord 2010;25:149–56.
22.McKeith, I, Cummings, J. Behavioural changes and psychological symptoms in dementia disorders. Lancet Neurol 2005;4:735–42.
23.Tucker, I. Management of inappropriate sexual behaviors in dementia: a literature review. Int Psychogeriatr 2010;22:683–92.
24.Ozkan, B, Wilkins, K, Muralee, S, Tampi, RR. Pharmacotherapy for inappropriate sexual behaviors in dementia: a systematic review of literature. Am J Alzheimers Dis Other Demen 2008;23:344–54.
25.Cicerone, KD, Langenbahn, DM, Braden, C, Malec, JF, Kalmar, K, Fraas, M, Felicetti, T, Laatsch, L, Harley, JP, Bergquist, T, Azulay, J, Cantor, J, Ashman, T. Evidence-based cognitive rehabilitation: updated review of the literature from 2003 through 2008. Arch Phys Med Rehabil 2011;92:519–30.
26.van Heugten, C, Gregório, GW, Wade, D. Evidence-based cognitive rehabilitation after acquired brain injury: a systematic review of content of treatment. Neuropsychol Rehabil 2012;22:653–73.
27.Chung, CS, Pollock, A, Campbell, T, Durward, BR, Hagen, S. Cognitive rehabilitation for executive dysfunction in adults with stroke or other adult non-progressive acquired brain damage. Cochrane Database Syst Rev 2013;4:CD008391.